Scholars@Duke

Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.

Publication ,  Journal Article
Klokker, L; Berthelsen, DB; Woodworth, T; Andersen, KM; Furst, DE; Devoe, D; Williamson, PR; Suarez-Almazor, ME; Strand, V; Leong, AL; Goel, N ...
Published in: J Rheumatol
September 2019
Published version (DOI) Link to item

OBJECTIVE: The Outcome Measures in Rheumatology (OMERACT) Safety Working Group objective was to identify harm domains from existing outcome measurements in rheumatology. METHODS: Systematically searching the MEDLINE database on January 24, 2017, we identified full-text articles that could be used for harm outcomes in rheumatology. Domains/items from the identified instruments were described and the content synthesized to provide a preliminary framework for harm outcomes. RESULTS: From 435 possible references, 24 were read in full text and 9 were included: 7 measurement instruments were identified. Investigation of domains/items revealed considerable heterogeneity in the grouping and approach. CONCLUSION: The ideal way to assess harm aspects from the patients' perspective has not yet been ascertained.

Duke Scholars

Niti Goel
Author Niti Goel Medicine, Rheumatology and Immunology

Published In

J Rheumatol

DOI

10.3899/jrheum.190196

EISSN

1499-2752

Publication Date

September 2019

Volume

46

Issue

9

Start / End Page

1173 / 1178

Location

Canada

Related Subject Headings

  • Rheumatology
  • Rheumatic Diseases
  • Outcome Assessment, Health Care
  • Humans
  • Clinical Trials as Topic
  • Arthritis & Rheumatology
  • Antirheumatic Agents
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Klokker, L., Berthelsen, D. B., Woodworth, T., Andersen, K. M., Furst, D. E., Devoe, D., … Christensen, R. (2019). Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials. J Rheumatol, 46(9), 1173–1178. https://doi.org/10.3899/jrheum.190196
Klokker, Louise, Dorthe B. Berthelsen, Thasia Woodworth, Kathleen M. Andersen, Daniel E. Furst, Dan Devoe, Paula R. Williamson, et al. “Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.” J Rheumatol 46, no. 9 (September 2019): 1173–78. https://doi.org/10.3899/jrheum.190196.
Klokker L, Berthelsen DB, Woodworth T, Andersen KM, Furst DE, Devoe D, et al. Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials. J Rheumatol. 2019 Sep;46(9):1173–8.
Klokker, Louise, et al. “Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials.” J Rheumatol, vol. 46, no. 9, Sept. 2019, pp. 1173–78. Pubmed, doi:10.3899/jrheum.190196.
Klokker L, Berthelsen DB, Woodworth T, Andersen KM, Furst DE, Devoe D, Williamson PR, Suarez-Almazor ME, Strand V, Leong AL, Goel N, Boers M, Brooks PM, March L, Sloan VS, Tugwell P, Simon LS, Christensen R. Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials. J Rheumatol. 2019 Sep;46(9):1173–1178.

Published In

J Rheumatol

DOI

10.3899/jrheum.190196

EISSN

1499-2752

Publication Date

September 2019

Volume

46

Issue

9

Start / End Page

1173 / 1178

Location

Canada

Related Subject Headings

  • Rheumatology
  • Rheumatic Diseases
  • Outcome Assessment, Health Care
  • Humans
  • Clinical Trials as Topic
  • Arthritis & Rheumatology
  • Antirheumatic Agents
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services